YS
Price:
$1.02
Market Cap:
$1.39B
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.[Read more]
Industry
Biotechnology
IPO Date
2021-08-05
Stock Exchange
NASDAQ
Ticker
YS
According to YS Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -44.72%. This represents a change of 290.95% compared to the average of -11.44% of the last 4 quarters.
The mean historical ROE of YS Biopharma Co., Ltd. over the last ten years is 10.96%. The current -44.72% ROE has changed -507.91% with respect to the historical average. Over the past ten years (40 quarters), YS's ROE was at its highest in in the March 2022 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -18.84%.
Average
10.96%
Median
15.17%
Minimum
-19.97%
Maximum
37.70%
Discovering the peaks and valleys of YS Biopharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 37.70%
Minimum Annual Increase = -231.68%
Minimum Annual ROE = -19.97%
Year | ROE | Change |
---|---|---|
2023 | -19.97% | -231.68% |
2022 | 15.17% | -59.77% |
The current ROE of YS Biopharma Co., Ltd. (YS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.96%
5-year avg
10.96%
10-year avg
10.96%
YS Biopharma Co., Ltd.’s ROE is greater than Revelation Biosciences, Inc. (-311.33%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Biodexa Pharmaceuticals Plc (-101.74%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Allarity Therapeutics, Inc. (-328.22%), less than Kiromic BioPharma, Inc. (327.18%), greater than Immix Biopharma, Inc. (-102.10%), less than CNS Pharmaceuticals, Inc. (695.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Zura Bio Limited (-39.61%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Virax Biolabs Group Limited (-115.10%),
Company | ROE | Market cap |
---|---|---|
-311.33% | $3.24M | |
-258.81% | $10.73M | |
-101.74% | $2.32M | |
-25512.50% | $2.65M | |
-398.33% | $2.50M | |
-328.22% | $5.63M | |
327.18% | $1.69M | |
-102.10% | $49.14M | |
695.91% | $7.15M | |
2.18% | $941.00 | |
-173.56% | $100.08K | |
-130.35% | $206.50K | |
-39.61% | $178.25M | |
-126.19% | $2.95M | |
-115.10% | $8.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YS Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like YS Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is YS Biopharma Co., Ltd.'s ROE?
How is the ROE calculated for YS Biopharma Co., Ltd. (YS)?
What is the highest ROE for YS Biopharma Co., Ltd. (YS)?
What is the 3-year average ROE for YS Biopharma Co., Ltd. (YS)?
What is the 5-year average ROE for YS Biopharma Co., Ltd. (YS)?
How does the current ROE for YS Biopharma Co., Ltd. (YS) compare to its historical average?